about
A relationship between oxytocin and anxiety of romantic attachmentSearch for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach.Serotonin transporter (SERT) and translocator protein (TSPO) expression in the obese ob/ob mouseFine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers.The expression of platelet serotonin transporter (SERT) in human obesity.Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromesPlatelet proteome and clopidogrel response in patients with stable angina undergoing percutaneous coronary intervention.Tubby protein in human lymphocytes from normal weight and obese subjects.New insight into benign tumours of major salivary glands by proteomic approach.Alteration of serotonin transporter density and activity in fibromyalgia.Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report.Clozapine effects on adenylyl cyclase activity and serotonin type 1A receptors in human brain post-mortem.N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation.Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells.Human serotonin transporter expression during megakaryocytic differentiation of MEG-01 cells.The trace element content of top-soil and wild edible mushroom samples collected in Tuscany, Italy.Variously substituted (phosphonoacetamido)oxy analogues of geranylgeranyl diphosphate (GGdP) as GGdP-transferase (GGTase) inhibitors and antiproliferative agents.Rosiglitazone reverses salbutamol-induced β(2) -adrenoceptor tolerance in airway smooth muscleEvaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glandsIn vitro effects of lead ions on peripheral benzodiazepine receptors and adenylyl cyclase activity in the mantle of Mytilus galloprovincialis.Proteome analysis of whole saliva: a new tool for rheumatic diseases--the example of Sjögren's syndrome.Detection of potential markers of primary fibromyalgia syndrome in human saliva.First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation.Male axillary extracts modify the affinity of the platelet serotonin transporter and impulsiveness in women.Alterations of the dopamine transporter in resting lymphocytes of patients with different psychotic disorders.A novel class of highly potent and selective A1 adenosine antagonists: structure-affinity profile of a series of 1,8-naphthyridine derivatives.Simultaneous analysis of clozapine, clomipramine and their metabolites by reversed-phase liquid chromatography.Synthesis, biological evaluation, and pharmacophore generation of new pyridazinone derivatives with affinity toward alpha(1)- and alpha(2)-adrenoceptors.Pharmacological characterization of the serotonin transporter in young and elderly subjects.Correlation between platelet alpha(2)-adrenoreceptors and symptom severity in major depression.Synthesis and biological activity of new 1,4-benzodioxan-arylpiperazine derivatives. Further validation of a pharmacophore model for alpha(1)-adrenoceptor antagonists.alpha(1)-Adrenoceptor antagonists. Rational design, synthesis and biological evaluation of new trazodone-like compounds.Conformationally restrained analogues of sympathomimetic catecholamines. Synthesis and adrenergic activity of 5,6- and 6,7-dihydroxy-3,4-dihydrospiro[naphthalen-1(2H)-2',5'-morpholines].Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients: influence of patient-related variables.New 1,2,3-triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors. II.Alpha(1)-adrenoceptor antagonists. 4. Pharmacophore-based design, synthesis, and biological evaluation of new imidazo-, benzimidazo-, and indoloarylpiperazine derivatives.Decreased inhibitory activity of PKC in OCD patients after six months of treatment.alpha1-Adrenoceptor antagonists. 5. Pyridazinone-arylpiperazines. Probing the influence on affinity and selectivity of both ortho-alkoxy groups at the arylpiperazine moiety and cyclic substituents at the pyridazinone nucleus.Studies of peripheral benzodiazepine receptors in mussels: comparison between a polluted and a nonpolluted site.[3H]-ketanserin binding sites in different psychiatric disorders.
P50
Q21203789-96E577E6-330D-46B1-8268-8CF04A9AABA3Q30009461-D35260B1-0825-47B0-9ED2-C8095CA5B1BBQ30998648-7505C8FC-2302-4482-8DF3-BF4CBA092253Q33356081-0C131BBA-2370-4E75-B6D1-D59BAB8CA2D4Q33591380-1EEBA96B-22DB-4676-8CDE-7D11E78A2390Q34083843-4865AC62-05D3-4956-AF00-078026CB2B04Q34225741-B96DA59A-CDFB-48F5-A019-724579D9EF9FQ34627853-3F43C1EA-7F00-469E-94A0-77136251ACDFQ35037000-067CFA62-DA41-440A-879B-854A2B1F31A0Q35605547-C971C2AE-F1B9-43DF-BA6E-1E925229937FQ35950644-1B00027B-E803-48BA-A09E-7FA27ECAFBADQ39271592-4473C0E6-F75E-45FD-9DCD-4A37DBA88F48Q39468979-99E553FC-176D-46C6-A350-3B03E006BEA4Q39589847-94B27E20-D75A-41FA-AB09-32188FBE9838Q39757807-B3733C6F-DF21-49A5-A491-18277C218D4CQ40023732-F5BD3BD5-E705-4C84-92F8-B64D68275B2EQ40265085-7C1A0BF7-F49B-44F5-BC99-AAD9FE3116A2Q41828663-61E18C93-8471-4656-9F76-92FF4227CCEFQ41920817-DC5DB6DE-60CD-4AF4-9D9E-87BC96CB4F99Q42459346-D748A572-0F95-4A68-A13E-315A47E22E7BQ42617298-4FD4C74C-125C-43F9-BA54-A7BF3AF2846FQ42784803-C490EFFC-3ACD-4AC5-B172-CBD43966CAEFQ43033736-45A1856B-E27F-4108-8642-B73DE7F6E2A6Q43116544-3A6D6692-1AB2-4023-8519-813504E70680Q43243308-C3947919-B73E-4A47-9B7B-B747C156BBCEQ43506369-A61C49D5-42AB-42B1-BAB1-B4E3D2663E1DQ43616083-DCE05590-DC75-404B-9508-1D650FFFE86CQ43639519-20048FCF-A75F-43F6-B7D5-224CABFCA804Q43699143-13DB9A6B-8A3D-49C2-AEEE-3DCCAAA2CAD4Q43756103-411BBCFA-B7C9-4C75-A9D3-19BE8DE4EBCEQ43821564-18E1C4E8-C09D-41FD-A6FD-B28D53AEB0A9Q43869013-87EDED0C-E9D2-4322-8147-1E6136DCA83FQ43884074-D970BED4-0E7B-4276-8260-FA0119BA4AA6Q43986056-F32A8B24-2BB1-4665-AC77-DEB034D0F82EQ44070294-E9BF9EE8-25CD-454D-B891-1F737AEE84A5Q44093508-FEA07D1C-77A5-4A6E-BC28-8169C54C29D4Q44105927-FB69F36F-DC67-4717-837F-C15767766AE4Q44249227-401EF960-0884-491A-BD65-5337EB327E91Q44290973-F0DC1F89-ADBA-4BE8-994A-817B33F6A617Q44291014-1713638E-DAA4-4719-92C7-6A3031F79E05
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gino Giannaccini
@ast
Gino Giannaccini
@en
Gino Giannaccini
@es
Gino Giannaccini
@nl
Gino Giannaccini
@sl
type
label
Gino Giannaccini
@ast
Gino Giannaccini
@en
Gino Giannaccini
@es
Gino Giannaccini
@nl
Gino Giannaccini
@sl
altLabel
G Giannaccini
@en
prefLabel
Gino Giannaccini
@ast
Gino Giannaccini
@en
Gino Giannaccini
@es
Gino Giannaccini
@nl
Gino Giannaccini
@sl
P106
P1153
7005506427
P21
P31
P496
0000-0001-6436-8187